Das Produkt wurde korrekt in den Warenkorb gelegt.

discount label
5Hexynoic-CTTHWGFTLC-OH
3D-Ansicht

Biosynth logo

5Hexynoic-CTTHWGFTLC-OH

Ref. 3D-PP47215

Unbestimmte GrößeNachfragen
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 5. November 2024

Produktinformation

Name:
5Hexynoic-CTTHWGFTLC-OH
Beschreibung:

Peptide 5Hexynoic-CTTHWGFTLC-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using 5Hexynoic-CTTHWGFTLC-OH include the following: Sustained release of a peptide-based matrix metalloproteinase-2 inhibitor to attenuate adverse cardiac remodeling and improve cardiac function following myocardial Z Fan , M Fu, Z Xu, B Zhang, Z Li, H Li , X Zhou - , 2017 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.biomac.7b00760 Tumor homing peptides as fusion partners of therapeutic proteins for efficient delivery to cancer cells YE Lee, BH Hwang - Biotechnology and Bioprocess Engineering, 2023 - Springerhttps://link.springer.com/article/10.1007/s12257-022-0139-0 Targeting matrix metalloproteinases and endothelial cells with a fusion peptide against tumor Y Zou, Y Chen, Y Jiang, J Gao, J Gu - Cancer research, 2007 - AACRhttps://aacrjournals.org/cancerres/article-abstract/67/15/7295/533413 A synthetic peptide inhibits human ovarian cancer cell motility Y Wei , D Huang , K Wang, J Du, Y Hu - RSC advances, 2015 - pubs.rsc.orghttps://pubs.rsc.org/en/content/articlehtml/2015/ra/c5ra08755d Development of brain targeting peptide based MMP-9 inhibiting nanoparticles for the treatment of brain diseases with elevated MMP-9 activity Y Islam, A Khalid, S Pluchino , M Sivakumaran - Journal of , 2020 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022354920303543 Targeting gelatinases with a near-infrared fluorescent cyclic His-Try-Gly-Phe peptide W Wang, R Shao, Q Wu, S Ke, J McMurray - Molecular imaging and , 2009 - Springerhttps://link.springer.com/article/10.1007/s11307-009-0219-y THPep: a machine learning-based approach for predicting tumor homing peptides W Shoombuatong , N Schaduangrat , R Pratiwi - biology and chemistry, 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1476927118309344 Systemic delivery of protein nanocages bearing CTT peptides for enhanced imaging of MMP-2 expression in metastatic tumor models T Kawano, M Murata, JS Piao, S Narahara - International journal of , 2014 - mdpi.comhttps://www.mdpi.com/1422-0067/16/1/148 A chimera of a gelatinase inhibitor peptide with streptavidin as a bifunctional tumor targeting reagent SJ Farlow, RJ Wang, MW Pandori , T Sano - FEBS letters, 2002 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0014579302025656 4 Development of R de Nooijer, KM Sliedregt-Bol - Modulation of the - scholarlypublications https://scholarlypublications.universiteitleiden.nl/access/item%3A2958289/download#page=80 A Phage Display Selected 7-mer Peptide Inhibitor of the Tannerella forsythia Metalloprotease-Like Enzyme Karilysin can be Truncated to Ser-Trp-Phe-Pro PD Skottrup, G Sorensen, M Ksiazek, J Potempa - PloS one, 2012 - journals.plos.orghttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0048537 Human tongue carcinoma growth is inhibited by selective antigelatinolytic peptides P Heikkila, J Suojanen, E Pirila - journal of cancer, 2006 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.21540 Binding of Novel Peptide Inhibitors of Type IV Collagenases to Phospholipid Membranes and Use in Liposome Targeting to Tumor Cells in Vitro OP Medina , T Söderlund, LJ Laakkonen - Cancer Research, 2001 - AACRhttps://aacrjournals.org/cancerres/article-abstract/61/10/3978/507449 Radionuclide imaging of tumor xenografts in mice using a gelatinase-targeting peptide OP Medina , K Kairemo, H Valtanen - Anticancer , 2005 - ar.iiarjournals.orghttps://ar.iiarjournals.org/content/25/1A/33.short Peptide-based selective inhibitors of matrix metalloproteinase-mediated activities MW Ndinguri, M Bhowmick , D Tokmina-Roszyk - Molecules, 2012 - mdpi.comhttps://www.mdpi.com/1420-3049/17/12/14230 Identification of a negatively charged peptide motif within the catalytic domain of progelatinases that mediates binding to leukocyte beta2 integrins M Stefanidakis, M Björklund , E Ihanus - Journal of Biological , 2003 - ASBMBhttps://www.jbc.org/article/S0021-9258(20)83788-0/abstract Use of intein-directed peptide biosynthesis to improve serum stability and bioactivity of a gelatinase inhibitory peptide M Bjorklund , H Valtanen, H Savilahti - Chemistry & High , 2003 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cchts/2003/00000006/00000001/art00004 Vascular-homing peptides for cancer therapy L Lu, H Qi, J Zhu, WX Sun, B Zhang, CY Tang - Biomedicine & , 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0753332217310879 Cy5. 5-c (Lys-Ala-His-Trp-Gly-Phe-Thr-Leu-Asp) NH 2 Cy5. 5-C6 K Leung - europepmc.orghttps://europepmc.org/books/n/micad/mmp-c6-cy55/ Cy5. 5-c (Lys-Ala-His-Trp-Gly-Phe-Thr-Leu-Asp) NH2 K Leung - 2010 - europepmc.orghttps://europepmc.org/article/nbk/nbk32323 In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models JE Sprague, WP Li, K Liang , S Achilefu - Nuclear medicine and , 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0969805105002714 Selective gelatinase inhibitor peptide is effective in targeting tongue carcinoma cell tumors in vivo J Suojanen, ST Vilen, P Nyberg, P Heikkila - Anticancer , 2011 - ar.iiarjournals.orghttps://ar.iiarjournals.org/content/31/11/3659.short Chemically synthesized matrix metalloproteinase and angiogenesis-inhibiting peptides as anticancer agents J Hu, M Yan, C Pu, J Wang - Anti-Cancer Agents , 2014 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/acamc/2014/00000014/00000003/art00012 Therapeutic Targeting of Angiogenesis with a Recombinant CTT Peptide-Endostatin Mimic-Kringle 5 Protein H Wang, Z Yang, J Gu - Molecular cancer therapeutics, 2014 - AACRhttps://aacrjournals.org/mct/article-abstract/13/11/2674/130808 Tumor targeting with a selective gelatinase inhibitor E Koivunen, W Arap, H Valtanen, A Rainisalo - Nature , 1999 - nature.comhttps://www.nature.com/articles/nbt0899_768 Bioconjugation of cyclometalated gold (III) lipoic acid fragments to linear and cyclic breast cancer targeting peptides D Śmià ‚owicz, JC Slootweg - Molecular , 2019 - ACS Publicationshttps://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.9b00695 Radiolabeled Matrix Metalloproteinase Inhibitors for Breast Cancer Therapy CJ Anderson , WASHINGTON UNIV ST LOUIS MO - 2002 - apps.dtic.milhttps://apps.dtic.mil/sti/citations/ADA410082 Targeting of gelatinase activity with a radiolabeled cyclic HWGF peptide B Kuhnast, C Bodenstein, R Haubner, HJ Wester - Nuclear medicine and , 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0969805103001859 Functional mimetic peptide discovery isolated by phage display interacts selectively to fibronectin domain and inhibits gelatinase A Shoari , MJ Rasaee , MR Kanavi - Journal of cellular , 2019 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/jcb.29276 Characterization of chemical, radiochemical and optical properties of a dual-labeled MMP-9 targeting peptide A Azhdarinia , N Wilganowski, H Robinson - Bioorganic & medicinal , 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0968089611003427 Peptide-based strategies for targeted tumor treatment and imaging A Ayo, P Laakkonen - Pharmaceutics, 2021 - mdpi.comhttps://www.mdpi.com/1999-4923/13/4/481

Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:

Chemische Eigenschaften

MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:

Gefahrenhinweise

UN-Nummer:
EQ:
Klasse:
H-Sätze:
P-Sätze:
Flugverbot:
Gefahrenhinweis:
Verpackungsgruppe:
LQ:

Technische Anfrage zu: 3D-PP47215 5Hexynoic-CTTHWGFTLC-OH

Bitte verwenden Sie stattdessen den Warenkorb, um ein Angebot oder eine Bestellung anzufordern

Wenn Sie ein Angebot anfordern oder eine Bestellung aufgeben möchten, legen Sie stattdessen die gewünschten Produkte in Ihren Warenkorb und fordern Sie dann ein Angebot oder eine Bestellung an aus dem Warenkorb. Es ist schneller, billiger und Sie können von den verfügbaren Rabatten und anderen Vorteilen profitieren.

* Obligatorische felder
Willkommen bei CymitQuimica!Wir verwenden Cookies, um Ihren Besuch zu verbessern. Wir schließen Werbung nicht ein.

Bitte beachten Sie unsere Cookie-Richtlinie  für weitere Details oder passen Sie Ihre Einstellungen unter “Konfigurieren” an.